Key Takeaways
- Discover why it is important that patients in clinical trials of new drugs should be ‘representative’ of the ultimate clinical population to receive the drug
- Understand the impact of under-representation in clinical trials
Who is this for?
This webinar is for those interested in including the correct representative population of older adults in their clinical trials.